Showing all 2 results
Clonazepam Tablets
FreeProduct Composition & Available Strengths
We supply Clonazepam across the complete, internationally standardized therapeutic spectrum to facilitate precise titration for both pediatric epilepsy and high-potency adult neurological control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clonazepam USP / BP / IP 0.5 mg
(500 mcg)
Oral / Sublingual Micro-Tablet Epilepsy Titration / Panic Baseline: For pediatric seizure disorders, low-dose stabilization, and initial panic management. Clonazepam USP / BP / IP 1.0 mg
(1000 mcg)
Oral / Sublingual Micro-Tablet Intermediate Maintenance: Step-up strength optimized for routine daily neurological maintenance without expanding tablet counts. Clonazepam USP / BP / IP 2.0 mg
(2000 mcg)
Oral High-Potency Solid Tablet Refractory Epilepsy & Acute Care: High-strength configuration calibrated for status epilepticus prophylaxis, myoclonic spasms, and manic stabilization. Oxcarbazepine Tablet
FreeProduct Composition & Available Strengths
We manufacture Oxcarbazepine in the full, internationally standardized range of strengths to allow for the precise, progressive dose titration mandatory in anti-epileptic therapy.
Active Ingredient Available Strengths Primary Clinical Target Oxcarbazepine IP / BP / USP 150 mg Pediatric & Initial Titration: For low-dose introductory phases to assess patient tolerance. Oxcarbazepine IP / BP / USP 300 mg Standard Maintenance: The foundational daily maintenance dose for adolescent and adult stabilization. Oxcarbazepine IP / BP / USP 600 mg High-Potency Control: For refractory focal seizures or high-threshold therapeutic stabilization.
